Prophylactic use of isepamicin and levofloxacin for transrectal prostate biopsy: a retrospective single center study.
Int J Urol
; 16(9): 723-5, 2009 Sep.
Article
em En
| MEDLINE
| ID: mdl-19638042
ABSTRACT
OBJECTIVES:
To evaluate the combination of isepamicin and levofloxacin in the prophylaxis of infectious complications associated with prostate biopsy (PBX).METHODS:
A total of 586 patients who underwent transrectal PBX in a single center were included in this retrospective analysis. They received 400 mg isepamicin once just before PBX plus 300 mg oral levofloxacin each day for three days as a rule. Clinical and laboratory data were evaluated.RESULTS:
A total of three (0.51%) patients presented a febrile complication after PBX. All of them were diagnosed as acute prostatitis. Serum white blood cell count and C-reactive protein in the 131 patients whose laboratory data were available for statistical analyses did not rise significantly after PBX.CONCLUSIONS:
Isepamicin plus fluoroquinolone can be considered a valuable regimen for antibiotic prophylaxis of PBX.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Próstata
/
Infecções Bacterianas
/
Ofloxacino
/
Antibioticoprofilaxia
/
Levofloxacino
/
Antibacterianos
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limite:
Aged
/
Aged80
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2009
Tipo de documento:
Article